This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a chiral building block in the creation of drugs targeting the central nervous system, where its cyclobutyl group can enhance binding affinity and selectivity. Additionally, it is employed in the production of small molecule inhibitors and modulators for various biological targets, including enzymes and receptors. Its hydrochloride form ensures stability and solubility, making it suitable for use in diverse chemical reactions and formulations. The compound is also explored in the development of novel therapeutics for conditions such as neurological disorders and chronic pain management.